Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Roche Holding AG (ROG)?s Lucentis works to treat a leading cause of blindness associated with diabetes, U.S. regulators said.
The injection improved vision in people with diabetic macular edema, Food and Drug Administration staff said in a report today ahead of a July 26 meeting of agency advisers on expanding approval of Lucentis. The drug is already used to treat wet age-related macular degeneration. Both diseases involve swelling of the macula, in the center of the retina.
Lucentis, if approved, would be the first drug cleared for diabetic macular oedema.
http://www.businessweek.com/news/20...ntis-works-to-treat-vision-loss-from-diabetes
The injection improved vision in people with diabetic macular edema, Food and Drug Administration staff said in a report today ahead of a July 26 meeting of agency advisers on expanding approval of Lucentis. The drug is already used to treat wet age-related macular degeneration. Both diseases involve swelling of the macula, in the center of the retina.
Lucentis, if approved, would be the first drug cleared for diabetic macular oedema.
http://www.businessweek.com/news/20...ntis-works-to-treat-vision-loss-from-diabetes